DE60216245D1 - Funktionelles oberflächendisplay von polypeptiden - Google Patents
Funktionelles oberflächendisplay von polypeptidenInfo
- Publication number
- DE60216245D1 DE60216245D1 DE60216245T DE60216245T DE60216245D1 DE 60216245 D1 DE60216245 D1 DE 60216245D1 DE 60216245 T DE60216245 T DE 60216245T DE 60216245 T DE60216245 T DE 60216245T DE 60216245 D1 DE60216245 D1 DE 60216245D1
- Authority
- DE
- Germany
- Prior art keywords
- polypeptides
- surface display
- functional surface
- display
- autotransporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01105129 | 2001-03-02 | ||
EP01105129 | 2001-03-02 | ||
PCT/EP2002/002246 WO2002070645A2 (en) | 2001-03-02 | 2002-03-01 | Functional surface display of polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60216245D1 true DE60216245D1 (de) | 2007-01-04 |
DE60216245T2 DE60216245T2 (de) | 2007-06-21 |
Family
ID=8176655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60216245T Expired - Lifetime DE60216245T2 (de) | 2001-03-02 | 2002-03-01 | Funktionelles oberflächendisplay von polypeptiden |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040259151A1 (de) |
EP (1) | EP1373571B1 (de) |
AT (1) | ATE346168T1 (de) |
AU (1) | AU2002249249A1 (de) |
DE (1) | DE60216245T2 (de) |
DK (1) | DK1373571T3 (de) |
WO (1) | WO2002070645A2 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004065415A2 (en) | 2003-01-20 | 2004-08-05 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | L-amino acid oxidase with cytotoxic activity from aplysia punctata |
US7253293B2 (en) * | 2004-01-06 | 2007-08-07 | Andrzej Slominski | Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof |
US8029777B2 (en) | 2004-08-13 | 2011-10-04 | Marshall Barry J | Helicobacter system and uses thereof |
JP2008509168A (ja) | 2004-08-13 | 2008-03-27 | マーシャル,バリー,ジェー. | 細菌デリバリシステム |
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
CN101889092A (zh) | 2007-10-04 | 2010-11-17 | 生物结构实验室公司 | 生物燃料生产 |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
DE102010035702A1 (de) * | 2010-08-27 | 2012-03-01 | Zyrus Beteiligungsgesellschaft Mbh & Co. Patente I Kg | Ganzzell-Biokatalysator |
WO2012038508A1 (en) * | 2010-09-23 | 2012-03-29 | Autodisplay Biotech Gmbh | Surface display of polypeptides containing a metal porphyrin or a flavin |
PL2622078T3 (pl) * | 2010-09-28 | 2015-05-29 | Abera Bioscience Ab | Białko fuzyjne dla ekspresji białka wydzielniczego |
EP2675474B1 (de) | 2011-02-15 | 2019-01-16 | Vaxiion Therapeutics, LLC | Therapeutische zusammensetzungen und verfahren für auf antikörper- und fc-haltigen molekülen basierende gezielte verabreichung bioaktiver moleküle durch bakterienminizellen |
EP2707482B1 (de) * | 2011-05-12 | 2015-09-09 | Autodisplay Biotech GmbH | Ganzzellen-biokatalysator mit einer prenyltransferase |
ES2604335T3 (es) | 2011-07-20 | 2017-03-06 | Evonik Degussa Gmbh | Oxidación y aminación de alcoholes primarios |
US20140308717A1 (en) | 2011-08-05 | 2014-10-16 | Evonik Degussa Gmbh | Oxidation and amination of secondary alcohols |
EP2602328A1 (de) | 2011-12-05 | 2013-06-12 | Evonik Industries AG | Verfahren zur Oxidation von Alkanen unter Verwendung einer AlkB Alkan 1-Monooxygenase |
EP2602329A1 (de) | 2011-12-05 | 2013-06-12 | Evonik Degussa GmbH | Biotechnologische Herstellung von 3-Hydroxyisobuttersäure |
EP2639308A1 (de) | 2012-03-12 | 2013-09-18 | Evonik Industries AG | Enzymatische omega-Oxidation und -Aminierung von Fettsäuren |
EP2653538A1 (de) | 2012-04-20 | 2013-10-23 | Evonik Industries AG | NADP-abhängige Alanindehydrogenase |
US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
WO2014139862A1 (en) * | 2013-03-13 | 2014-09-18 | Autodisplay Biotech Gmbh | Improved surface display of functional proteins in a broad range of gram negative bacteria |
US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4344350C2 (de) * | 1993-12-23 | 1995-09-21 | Max Planck Gesellschaft | Bakterien zur Herstellung stabiler Fusionsproteine und Verfahren zu deren Nachweis |
US6686168B1 (en) * | 1999-11-04 | 2004-02-03 | Zymogenetics, Inc. | Cell surface display of proteins by recombinant host cells |
-
2002
- 2002-03-01 WO PCT/EP2002/002246 patent/WO2002070645A2/en active IP Right Grant
- 2002-03-01 EP EP02718168A patent/EP1373571B1/de not_active Expired - Lifetime
- 2002-03-01 AT AT02718168T patent/ATE346168T1/de active
- 2002-03-01 DK DK02718168T patent/DK1373571T3/da active
- 2002-03-01 AU AU2002249249A patent/AU2002249249A1/en not_active Abandoned
- 2002-03-01 DE DE60216245T patent/DE60216245T2/de not_active Expired - Lifetime
- 2002-03-01 US US10/469,723 patent/US20040259151A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002070645A2 (en) | 2002-09-12 |
ATE346168T1 (de) | 2006-12-15 |
AU2002249249A1 (en) | 2002-09-19 |
DK1373571T3 (da) | 2007-04-16 |
WO2002070645A3 (en) | 2003-07-24 |
EP1373571A2 (de) | 2004-01-02 |
US20040259151A1 (en) | 2004-12-23 |
EP1373571B1 (de) | 2006-11-22 |
DE60216245T2 (de) | 2007-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE346168T1 (de) | Funktionelles oberflächendisplay von polypeptiden | |
DE60041505D1 (de) | Inzektizide proteinen von bacillus thuringiensis | |
DE69823046D1 (de) | Praktische in vitro sialylierung von rekombinanten glykpproteinen | |
ATE460429T1 (de) | Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb | |
ATE227739T1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
DE69731226D1 (de) | Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten | |
DE69812773D1 (de) | Methode zur de novo Peptidsequenz-Bestimmung | |
ATE454393T1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
DE69831777D1 (de) | Framework zur finanziellen Integration von Geschäftsapplikationen | |
ATE490323T1 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
FI943389A0 (fi) | Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö | |
DE60207053D1 (de) | Rekombinante gelatineartige proteine zur verwendung als plasmaexpander | |
DE69823525D1 (de) | Verfahren zur hochauflösenden identifizierung von lösungsmittel-zugänglichen amidhydrogenen in polypeptiden | |
ATE323763T1 (de) | Dna & protein bindende miniatur proteine | |
DE60026774D1 (de) | Defekterkennung mit Verwendung von Grauwertsignaturen | |
NO972063L (no) | Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle | |
WO2005044845A3 (en) | Protein binding miniature proteins | |
DK0826054T3 (da) | Ekspression af glycosyltransferase i Aspergillus | |
DE60210970D1 (de) | Mutante formen von etxb und ctxb und ihre verwendung als träger | |
DE60327426D1 (de) | Markierung von substraten | |
DE60334316D1 (de) | Frpb proteinmutante und verfahren zur erneuten faltung | |
ATE379816T1 (de) | Architektur zum verarbeiten von fingerabdruckbildern | |
DE60314890D1 (de) | Verfahren zur leitweglenkung von datenpaketen, und vorrichtungen zur implementierung dieses verfahrens | |
ATE307201T1 (de) | Srcr domäne-enthaltendes protein | |
BR0308321A (pt) | Inibidores da peptìdeo deformilase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ZYRUS BETEILIGUNGSGESELLSCHAFT MBH & CO. PATEN, DE |